• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FRESENIUS MEDICAL CARE NORTH AMERICA CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FRESENIUS MEDICAL CARE NORTH AMERICA CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 03-2722-9
Device Problem Detachment Of Device Component (1104)
Patient Problem Blood Loss (2597)
Event Date 04/26/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).No parts were returned to the manufacturer for physical evaluation.The post market surveillance department received medical records associated with the reported event.Both a clinical investigation and plant investigation are in process.A supplemental mdr will be submitted upon completion of these activities.
 
Event Description
A spontaneous, serious blood loss event, which occurred during a hemodialysis (hd) treatment, was reported to fmcna, llc by a nurse from the user facility on (b)(6) 2016.The report concerns a (b)(6) patient with end stage renal disease (esrd) on chronic hemodialysis.On (b)(6) 2016, at 4:00 pm, while the patient underwent a routinely scheduled dialysis treatment, the needle line disconnected from the bloodline.The separation occurred approximately 2 hours and 15 minutes into the treatment and resulted in an episode of blood loss.The patient's estimated blood loss (ebl) was noted as being approximately 500ml.The patient was found to be unresponsive, but with a carotid pulse.Supplemental oxygen was administered.The blood pump was stopped, and the bleeding was addressed; a normal saline bolus was started.The patient initially reported no symptoms upon regaining consciousness, but soon developed nausea and experienced chest pressure.The patient vomited, and then their blood pressure was found to have dropped to its lowest monitored value of 58/43.A total of 2.6 liters of normal saline (ns) was administered.The patient reported feeling better; both the chest pressure and nausea experienced by the patient had subsided.The medical doctor (md) responded and assisted at chairside; emergency medical services (ems) were contacted through chairside (as per md orders) and 1000cc of normal saline (ns) was administered.A peripheral intravenous (iv) line was placed by ems upon their arrival.Following placement of the peripheral iv line, the patient's arteriovenous (av) graft lines were removed, and an additional 1000cc of ns was administered.The patient's blood pressure was noted as being 126/35 at the time of transfer from unit by ems.Patient alert and oriented times 3.The patient was transferred to, and then admitted to the hospital, where 1 unit of packed red blood cells was transfused.The patient was subsequently discharged from the hospital on the same day.The patient has since recovered from this event, and was scheduled to return to receiving routine hd treatments at their home facility beginning (b)(6) 2016.Following the event, the 2008t hemodialysis (hd) machine was pulled from service for evaluation.The onsite biomedical technician performed functional testing and verified the unit was in good operating condition.Unit passed all testing; no repairs or calibrations required.Additionally, no bloodline device issues were visible; specifically, no holes, separations, or tubing deficiencies observed.The fresenius bloodline is not available for evaluation as it was discarded by the user facility.
 
Manufacturer Narrative
The device was not returned to the manufacturer for physical evaluation, and the lot number was not provided.Therefore, the failure mode cannot be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.A manufacturing review was performed of the products shipped to the dialysis center for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius bloodlines from the reported catalog number (03-2722-9) shipped to this account within the selected time frame.A records review was performed on the fifteen (15) lots identified.An investigation of the device manufacturing records was conducted by the manufacturer.There were no deviations or non-conformances identified during the manufacturing process which could be associated with the reported event.In addition, the batch record review confirmed the labeling, material, and process controls were within specification.The lots passed all release criteria.A review of the batch production records did not reveal a probable cause for the customer complaint.There were no non-conformances identified that relate to the reported event, and all lots met release criteria.Therefore, the reported adverse event was not able to be confirmed as it relates to the fresenius bloodline.
 
Manufacturer Narrative
Clinical investigation: the patient medical records were provided by the facility on june 1, 2016.A clinical investigation was performed to determine any possible causal relationship between the hemodialysis treatment and the adverse event.A (b)(6), female end stage renal disease (esrd) patient presented to an in-center clinic on (b)(6) 2016 for a routine hemodialysis session.At approximately 4:00 pm, the patient¿s blood pressure (bp) was recorded at 58/43 and the hd venous needle was found to be disconnected from the bloodline set.The line was clamped, and then the hd treatment was terminated.The patient endured a temporary loss of consciousness.The patient received a saline bolus, and regained consciousness (total saline administered was 2.6 liters).Shortly thereafter, the patient complained of chest pressure and nausea, which resolved after the patient¿s bp was restored to normal readings (123/46).The patient was transported to the hospital and admitted to the emergency room (er) where she received one unit of packed red blood cells (prbc).Patient was discharged the same day.Additionally, the patient resumed regularly scheduled hd treatments on (b)(6) 2016.The medical record revealed that the blood loss was a direct result of the patient¿s hd venous needle becoming disconnected from the venous bloodline set.The bloodline is connected to the cannula of the venous needle.The venous needle with cannula is not manufactured by fresenius medical care.There was no allegation that the blood loss was caused by a loose or faulty connection.There is no documentation in the medical record to conclude that there was a causal relationship between the 2008t hemodialysis (hd) machine or the fresenius bloodline and the patient¿s blood loss, low bp, or transient unresponsiveness leading to hospitalization.In addition, the 2008t hemodialysis machine operator¿s manual (p/n 490122 rev.N) contains the following warning on pg.103 related to the occurrence of low venous pressure alarms.The low venous pressure alarm may not occur with every disconnection or needle dislodgement.Check all bloodlines for leaks after the treatment has started.Keep access sites uncovered and monitored.Improper bloodline connections or needle dislodgements can result in excessive blood loss, serious injury, and death.Machine alarms may not occur in every blood loss situation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUSTOM COMBI SET
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
FRESENIUS MEDICAL CARE NORTH AMERICA
mike allen #1331
parque industrial reynosa
reynosa, tamaulipas cp 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa, tamaulipas cp 88780
MX   88780
Manufacturer Contact
tanya taft
920 winter st.
waltham, MA 02451
7816999000
MDR Report Key5697853
MDR Text Key46512443
Report Number8030665-2016-00264
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 07/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03-2722-9
Other Device ID Number00840861100293
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/10/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age66 YR
Patient Weight68
-
-